Early Signs of Atherosclerosis in Obstructive Sleep Apnea: Effects of Treatment

Completed

Phase 4 Results

Summary of Purpose

Obstructive sleep apnea (OSA) is associated with adverse cardiovascular outcomes, including acute myocardial infarction and stroke. Atherosclerosis is an important step for these events. Recent studies demonstrated the independent association between OSA and validated markers of atherosclerosis. However, the impact of treatment with continuous positive airway pressure (CPAP) on these markers is unknown. ...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 November 2006.

1 Jan 2004 16 Nov 2006 Unavailable 1 Jul 2006 1 Nov 2006 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available